Most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term, according to a new study reported in JAMA Network Open.
Global stock market crash likely to delay biotech IPOs – Pharmaceutical Technology
Biotech IPOs raised a total of $3.72bn in the first quarter of this year. Image credit: Shutterstock / ImageFlow. Initial public offerings (IPOs) for biotechs